Glaucoma Care in Gurgaon

Dr Shibal Bhartiya glaucoma specialist Gurgaon examining optic nerve during superspecialty consultation

Glaucoma is the leading cause of irreversible blindness worldwide. It is a progressive optic nerve disease that can silently damage vision much before symptoms become obvious. Early diagnosis, OCT imaging, visual field testing, and long-term monitoring are essential to reducing the risk of irreversible vision loss.

Superspecialty glaucoma care means catching that damage early, tracking it precisely, and making treatment decisions that are built around your individual risk, not a standard protocol.

Glaucoma Care in Gurgaon: Diagnosis, Treatment, and Second Opinions

Most people who arrive at a glaucoma consultation did not expect to be there.

Perhaps a routine eye check flagged your optic nerve. Maybe a parent lost vision to glaucoma and you want to know your own risk. Perhaps you have been on drops for years and something still doesn’t feel right. Whatever brought you here, you are asking the right question at the right time, because in glaucoma, timing is everything.

The nerve fibres that glaucoma destroys do not regenerate. Vision lost to this disease does not return. But vision that has not yet been lost can almost always be protected, if the disease is identified accurately, monitored carefully, and managed by a specialist with the training to interpret what the tests are actually showing.

This is what superspecialty glaucoma care means in practice.

What Glaucoma Actually Is

Glaucoma is not a single disease. It is a family of conditions that share one defining feature: progressive damage to the optic nerve, the cable that carries visual information from your eye to your brain.

In most forms of glaucoma, elevated intraocular pressure — the fluid pressure inside the eye — is the primary driver of that damage. But pressure is not the whole story. Roughly a third of glaucoma patients have pressures that fall within the normal range. In these patients, the nerve is vulnerable for reasons that go beyond simple mechanics — vascular supply, structural anatomy, and systemic factors all play a role.

This is why glaucoma cannot be managed by pressure alone. It requires a trained eye on the nerve itself.

The most common forms of glaucoma

Primary open-angle glaucoma is the most prevalent form globally and in India. It develops slowly, painlessly, and without warning. By the time peripheral vision is affected, significant nerve damage has usually already occurred.

Normal tension glaucoma is systematically underdiagnosed in India. Patients with pressures in the normal range are often reassured and discharged — while damage continues. Identifying this condition requires looking beyond the pressure reading.

Angle-closure glaucoma is more common in Asian populations. It can present as a sudden, painful emergency — or develop slowly and silently in the chronic form. A detailed anterior segment assessment is essential to detect the anatomical risk before a crisis occurs.

Childhood and secondary glaucomas require specialist evaluation. Secondary glaucomas — arising from inflammation, steroid use, trauma, or systemic conditions — are frequently missed or mismanaged without subspecialty input.

Why Superspecialty Training Changes Outcomes

A general ophthalmologist is trained to detect glaucoma and initiate treatment. A fellowship-trained glaucoma subspecialist is trained to do something more precise: to distinguish true progression from test variability, to select the right intervention at the right disease stage, and to manage the full complexity of a condition that evolves over decades.

The difference becomes most visible in three situations.

When the diagnosis is uncertain. Glaucoma suspects — patients with suspicious optic nerves or borderline pressures who do not yet meet diagnostic criteria — require careful longitudinal monitoring. The decision of when to treat, and how aggressively, requires experienced clinical judgement.

When progression occurs despite treatment. Patients who worsen on drops are not simply non-compliant. They may have nocturnal pressure spikes, inadequate pressure targets, or structural vulnerability that requires a different therapeutic approach entirely.

When surgery is on the table. The glaucoma surgical landscape has changed significantly with the advent of MIGS — minimally invasive glaucoma surgery. Knowing when MIGS is appropriate, which device fits which patient, and when conventional filtration surgery remains the better option requires a surgeon who operates across the full spectrum.

What to Expect at This Practice

My approach to glaucoma care is built around four principles.

Catch it before it matters. Early detection requires looking beyond the standard pressure check — at the optic nerve structure, the retinal nerve fibre layer on OCT, and the visual field pattern over time. I look for the signal before the symptom.

Track it with precision. A single test is a photograph. Glaucoma management requires a series of photographs — read by someone who understands what change looks like, and what normal variation looks like. I review trends, not snapshots.

Treat it at the right stage. Not every glaucoma patient needs surgery. Not every glaucoma patient can be managed on drops alone. The treatment plan is built around your disease stage, your lifestyle, your pressure target, and your individual risk of progression.

Protect the ocular surface. Long-term glaucoma drops affect the surface of the eye in a significant proportion of patients. Ocular surface disease reduces comfort, affects adherence, and is frequently undertreated. I address it as part of glaucoma management — not as a separate problem.

Glaucoma Care Covered in This Practice

Diagnosis and Detection

Medical Management

Monitoring and Progression

Surgery

Local and General

When to Come In

Book a superspecialty consultation if any of the following apply:

  • You have been told your optic nerve looks “suspicious” or “cupped”
  • You have a parent or sibling with glaucoma
  • You are on glaucoma drops and have never had a formal progression assessment
  • Your visual fields are worsening despite treatment
  • You have been recommended surgery and want a second opinion
  • You have high myopia — a significant independent risk factor for glaucoma
  • You use steroid drops, inhalers, or nasal sprays regularly

Glaucoma does not announce itself. By the time you notice something is wrong, the window for easy intervention may already be narrowing. Early assessment costs very little. Late diagnosis costs vision.

Frequently Asked Questions

What is the difference between a glaucoma specialist and a general eye doctor?

A glaucoma specialist has completed a dedicated fellowship — one to two years of focused training in glaucoma diagnosis, medical management, laser, and surgery — beyond standard ophthalmology residency. This training matters most in uncertain diagnoses, complex progression, and surgical planning.

How often should I have my eyes checked if I have glaucoma?

Most patients with established glaucoma require review every three to six months, including IOP measurement, OCT, and periodic visual field testing. The exact frequency depends on your disease stage, stability, and treatment response. Suspects require annual or biannual monitoring.

Can glaucoma be cured?

Glaucoma cannot currently be cured — but in the vast majority of patients, it can be controlled well enough to preserve functional vision for life. The key is early detection, accurate monitoring, and treatment that is adjusted as the disease evolves.

Is glaucoma hereditary?

Yes. First-degree relatives of glaucoma patients have a four to nine times higher risk of developing the condition. Screening siblings and adult children of affected patients is one of the most cost-effective interventions in glaucoma prevention.

What is MIGS and am I a candidate?

MIGS — minimally invasive glaucoma surgery — is a family of procedures designed to lower eye pressure with a safer profile than traditional filtration surgery. It is most appropriate for mild to moderate glaucoma. Not every patient is a candidate; appropriate selection requires subspecialty assessment.

You may want to listen to Dr Bhartiya answer some frequently asked questions here.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Here are some patient stories

The English Teacher Who Began Painting Again

How to do visual fields

Uveitic glaucoma